Danaher (NYSE: DHR) grants options and RSUs to chief science officer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Danaher Corporation reported equity awards for SVP and Chief Science Officer Jose-Carlos Gutierrez-Ramos. He received 17,964 employee stock options and 6,647 shares of common stock as a grant on March 1, 2026. The footnotes state that 25% of the restricted stock units vest on each of the first four anniversaries of the grant date, and 50% of the options become exercisable on each of the third and fourth anniversaries. In a related tax-withholding transaction, 284 shares of common stock were disposed of at $210.64 per share, leaving him with 19,018 common shares directly owned after these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Gutierrez-Ramos Jose-Carlos
Role
SVP, Chief Science Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee stock option (right to buy) | 17,964 | $0.00 | -- |
| Grant/Award | Common Stock | 6,647 | $0.00 | -- |
| Tax Withholding | Common Stock | 284 | $210.64 | $60K |
Holdings After Transaction:
Employee stock option (right to buy) — 17,964 shares (Direct);
Common Stock — 19,302 shares (Direct)
Footnotes (1)
- On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. Twenty-five percent of the RSUs vest on each of the first four anniversaries of the grant date, which is March 1, 2026. Fifty percent of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is March 1, 2026.
FAQ
What equity awards did Danaher (DHR) grant to Jose-Carlos Gutierrez-Ramos?
Danaher granted Jose-Carlos Gutierrez-Ramos 17,964 employee stock options and 6,647 shares of common stock on March 1, 2026. These awards are part of his compensation as SVP and Chief Science Officer and follow specified multi-year vesting schedules.
How do the restricted stock units for Danaher (DHR) executive vest?
The restricted stock units vest in four equal parts, with 25% vesting each year on the first four anniversaries of the March 1, 2026 grant date. This structure encourages longer-term alignment between the executive and Danaher’s shareholders over several years.
What is the vesting schedule for the Danaher (DHR) stock options granted?
The filing states that 50% of the stock options become exercisable on each of the third and fourth anniversaries of the March 1, 2026 grant date. This back-loaded vesting delays exercisability, linking potential option value to longer-term company performance.
Are the Danaher (DHR) equity awards to the chief science officer immediately exercisable or fully vested?
No, both awards vest over time. The restricted stock units vest 25% per year over four years, and the stock options vest 50% on each of the third and fourth anniversaries. This staggered schedule ties executive compensation to multi-year company performance.